Xia Chun-Ling, Lyu Yuan, Li Chuang, Li Huan, Zhang Zhi-Tao, Yin Shao-Wei, Mao Yan, Li Wen, Kong Ling-Yin, Liang Bo, Jiang Hong-Kun, Li-Ling Jesse, Liu Cai-Xia, Wei Jun
Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning Centre for Prenatal Diagnosis, Research Center of China Medical University Birth Cohort, Department of Gynecology & Obstetrics, Shengjing Hospital affiliated to China Medical University, Shenyang, China.
Basecare Medical Device Co., Ltd., Suzhou, China.
Front Genet. 2019 Nov 15;10:1161. doi: 10.3389/fgene.2019.01161. eCollection 2019.
Silver-Russell syndrome (SRS) is a rare, well-recognized disorder characterized by growth restriction, including intrauterine and postnatal growth. Most SRS cases are caused by hypomethylation of the paternal imprinting center 1 (IC1) in chromosome 11p15.5 and maternal uniparental disomy in chromosome 7 (UPD7). Here, we report on a Chinese family with a 4 year old male proband presenting with low birth weight, growth retardation, short stature, a narrow chin, delayed bone age, and speech delays, as a result of a rare molecular etiology. Whole-exome sequencing was conducted, and a novel splicing variant, NM_000612.4: c.157+5G > A, was identified on the paternal allele. functional analysis by RT-PCR and Sanger sequencing revealed that the variant leads to an aberrant RNA transcript lacking exon 2. Our results further confirm the variant mediates SRS and expand the pathogenic variant and phenotypic spectrum of -mediated SRS. The results indicate that, beyond DNA methylation and UPD7 and variant tests, gene screening should also be considered for SRS molecular diagnoses.
Silver-Russell综合征(SRS)是一种罕见的、广为人知的疾病,其特征为生长受限,包括宫内和出生后生长。大多数SRS病例是由11号染色体p15.5区域父源印记中心1(IC1)的低甲基化以及7号染色体母源单亲二倍体(UPD7)引起的。在此,我们报告一个中国家庭,其4岁男性先证者因罕见的分子病因,表现为低出生体重、生长发育迟缓、身材矮小、下巴狭窄、骨龄延迟和语言发育迟缓。进行了全外显子组测序,在父源等位基因上鉴定出一个新的剪接变体,NM_000612.4:c.157+5G>A。通过逆转录聚合酶链反应(RT-PCR)和桑格测序进行的功能分析表明,该变体导致缺少外显子2的异常RNA转录本。我们的结果进一步证实该变体介导SRS,并扩展了介导SRS的致病变体和表型谱。结果表明,除了DNA甲基化、UPD7和变体检测外,SRS分子诊断还应考虑基因筛查。